NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 578 / 982

  1. Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder2017 · Crossref
  2. Multidimensional Tensor Scan for Drug Overdose Surveillance2017 · Crossref
  3. Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies2017 · OpenAlex
  4. Multilevel Prevention Trial of Alcohol Use Among American Indian and White High School Students in the Cherokee Nation2017 · Crossref
  5. Multimodal mental imagery2017 · OpenAlex
  6. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder2017 · Crossref
  7. Multiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluorophenmetrazine and U-477002017 · OpenAlex
  8. Multiple DSM‐5 substance use disorders: A national study of US adults2017 · Crossref
  9. Multiple Fentanyl Overdoses — New Haven, Connecticut, June 23, 20162017 · OpenAlex
  10. Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing2017 · OpenAlex
  11. Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain2017 · OpenAlex
  12. Multiplexed CRISPR/Cas9‐mediated metabolic engineering of γ‐aminobutyric acid levels in Solanum lycopersicum2017 · OpenAlex
  13. Multivariate analysis of energy dispersive X-ray diffraction data for the detection of illicit drugs in border control2017 · OpenAlex
  14. Music tourism and factions of bodies in Goa2017 · OpenAlex
  15. Mystic Acetaldehyde: The Never-Ending Story on Alcoholism2017 · OpenAlex
  16. Mystical mobilities and entheogenic Latin America2017 · OpenAlex
  17. N -Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities2017 · Crossref
  18. Nalmefene Prevents Alcohol‐Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR42017 · Crossref
  19. Naloxone Administration for Opioid Overdose Reversal in the Prehospital Setting: Implications for Pharmacists2017 · Crossref
  20. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people’s perceptions of the BC take home naloxone program2017 · OpenAlex
  21. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.2017 · PubMed
  22. Naloxone Potentiates the Plasma Catecholamine Response to Asphyxia in the Fetus2017 · Crossref
  23. Naloxone prolongs cutaneous nociceptive block by lidocaine in rats2017 · Crossref
  24. Naloxone rescheduling in Australia: Processes, implementation and challenges with supply of naloxone as a ‘pharmacist only’ over‐the‐counter medicine2017 · Crossref
  25. Naloxone-Induced Jumping in Morphine Dependent Mice: Stimulus Control and Motivation2017 · Crossref
  26. Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review2017 · Crossref
  27. Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids2017 · OpenAlex
  28. Narcotráfico en la Darkweb: los criptomercados/ Illicit Drug Trafficking on the Darkweb: Criptomarkets2017 · Crossref
  29. Narrative review: The Meaning of “Recovery” for Addiction Treatment and Research2017 · OpenAlex
  30. Narratives of Young Men With Injecting Drug Use Histories Leaving Adult Prison2017 · Crossref
  31. National trends in long‐term use of prescription opioids2017 · Crossref
  32. Nationalism on Their Own Terms: The National Products Movement and the Coca-Cola protest in Shanghai, 1945–19492017 · Crossref
  33. Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor2017 · OpenAlex
  34. Natural Products as a Source for Novel Analgesic Compounds2017 · OpenAlex
  35. NATURALIZING PSYCHEDELIC SPIRITUALITY2017 · OpenAlex
  36. Navigating intimacy with ecstasy: The emotional, spatial and boundaried dynamics of couples’ MDMA experiences2017 · OpenAlex
  37. NBOMe Compounds: Systematic Review and Data Crunching of the Surface Web2017 · OpenAlex
  38. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis2017 · OpenAlex
  39. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.2017 · PubMed
  40. Negative Affect‐Associated USV Acoustic Characteristics Predict Future Excessive Alcohol Drinking and Alcohol Avoidance in Male P and NP Rats2017 · Crossref
  41. Neighborhood Characteristics, Alcohol Outlet Density, and Alcohol-Related Calls-for-Service: A Spatiotemporal Analysis in a Wet Drinking Country2017 · Crossref
  42. Neonatal Abstinence Syndrome in East Tennessee: Characteristics and Risk Factors among Mothers and Infants in One Area of Appalachia2017 · OpenAlex
  43. Nephrotoxicity effects of Khat (Catha edulis) on mice when administered orally2017 · OpenAlex
  44. Neural basis of major depressive disorder: Beyond monoamine hypothesis2017 · OpenAlex
  45. Neural connectivity in Internet gaming disorder and alcohol use disorder: A resting-state EEG coherence study2017 · OpenAlex
  46. Neural Mechanisms of Circadian Regulation of Natural and Drug Reward2017 · OpenAlex
  47. Neural mechanisms of extinguishing drug and pleasant cue associations in human addiction: role of the VMPFC2017 · Crossref
  48. Neural responses to negative outcomes predict success in community‐based substance use treatment2017 · Crossref
  49. Neural substrates of cue reactivity and craving in gambling disorder2017 · OpenAlex
  50. Neurobehavioral Changes Produced by Developmental Exposure to Benzodiazepines2017 · Crossref
  51. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders2017 · Crossref
  52. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice2017 · OpenAlex
  53. Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study2017 · OpenAlex
  54. Neurodevelopmental profile of Fetal Alcohol Spectrum Disorder: A systematic review2017 · OpenAlex
  55. Neuroimage Studies: The Effect of Methylphenidate in Cocaine Users with ADHD2017 · Crossref
  56. Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis2017 · OpenAlex
  57. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency2017 · OpenAlex
  58. Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis2017 · OpenAlex
  59. Neurological Aspects of Medical Use of Cannabidiol2017 · OpenAlex
  60. Neuromodulatory Systems and Their Interactions: A Review of Models, Theories, and Experiments2017 · OpenAlex
  61. Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats2017 · OpenAlex
  62. Neuropathic Pain and Sleep: A Review2017 · OpenAlex
  63. Neuropeptide Y in Alcohol Addiction and Affective Disorders2017 · OpenAlex
  64. Neuropharmacological characterization of the new psychoactive substance methoxetamine2017 · OpenAlex
  65. Neuroprotective activity of macamides on manganese-induced mitochondrial disruption in U-87 MG glioblastoma cells2017 · OpenAlex
  66. Neuroprotective effect of Bacopa monnieri against morphine-induced histopathological changes in the cerebellum of rats2017 · Crossref
  67. Neuroprotective effects of eugenol against aluminiuminduced toxicity in the rat brain2017 · OpenAlex
  68. Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease2017 · OpenAlex
  69. Neuropsychological functioning in college students who misuse prescription stimulants2017 · OpenAlex
  70. Neuroretinal Dysfunctions in Regular Cannabis Users: An Impact of Cannabis on Retinal Neurotransmission?2017 · Crossref
  71. Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders2017 · Crossref
  72. Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis.2017 · PubMed
  73. Neurovascular unit alteration in somatosensory cortex and enhancement of thermal nociception induced by amphetamine involves central AT 1 receptor activation2017 · OpenAlex
  74. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples2017 · OpenAlex
  75. New designer benzodiazepines use in Barcelona2017 · Crossref
  76. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults.2017 · PubMed
  77. New Persistent Opioid Use Among Patients With Cancer After Curative-Intent Surgery2017 · OpenAlex
  78. NEW PERSPECTIVES ON MEDICINAL PROPERTIES AND USES OF IRIS SP.2017 · Crossref
  79. New Psychoactive Substances (NPS) – a Challenge for the Addiction Treatment Services2017 · Crossref
  80. NEW PSYCHOACTIVE SUBSTANCES AS A CRIME OBJECT2017 · Crossref
  81. New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–20152017 · OpenAlex
  82. New psychoactive substances of natural origin: A brief review.2017 · PubMed
  83. New psychoactive substances: a public health issue2017 · OpenAlex
  84. New psychoactive substances: Purchasing and supply patterns in Australia2017 · OpenAlex
  85. New Psychoactive Substances: Risks and Challenges2017 · Crossref
  86. New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis.2017 · PubMed
  87. New Trends in Paracoccidioidomycosis Epidemiology2017 · OpenAlex
  88. Newer insights into the Psychoactive and Pharmacological Properties of Datura stramonium Linn2017 · OpenAlex
  89. Newly Emerging Drugs of Abuse and Their Detection Methods2017 · OpenAlex
  90. Nicolas Langlitz, Neuropsychedelia. The revival of hallucinogen research since the Decade of the brain2017 · OpenAlex
  91. Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans2017 · OpenAlex
  92. Nicotine in floral nectar pharmacologically influences bumblebee learning of floral features2017 · OpenAlex
  93. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.2017 · PubMed
  94. Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations2017 · OpenAlex
  95. Nilai Diagnostik dan Peran Pemeriksaan Indeks Kolapsibilitas Diameter Vena Kava Inferior dalam Menilai Berat Kering pada Pasien Hemodialisis2017 · Crossref
  96. Nitrous oxide (N2O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial2017 · OpenAlex
  97. NMR-Based Metabolic Profiling of Field-Grown Leaves from Sugar Beet Plants Harbouring Different Levels of Resistance to Cercospora Leaf Spot Disease2017 · Crossref
  98. No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir2017 · Crossref
  99. No effects of increased alcohol availability during adolescence on alcohol-related morbidity and mortality during four decades: a natural experiment2017 · Crossref
  100. No Evidence That Substance Use Causes ADHD Symptoms in Adolescence2017 · Crossref